Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Genitourinary Cancers
•
Prostate Cancer
Would you offer modest hypofractionation (e.g. 70 Gy/28 fractions) to a patient with intermediate risk prostate cancer and celiac disease?
Answer from: Radiation Oncologist at Community Practice
Celiac disease is primary small bowel disease. RT effect on rectum would not be exaggerated from the disease.
Sign in or Register to read more
5901
Related Questions
Would you consider adding abiraterone to ADT and salvage RT in a prostate cancer patient with pN1 disease at radical prostatectomy?
Do you still order mpMRI for staging of prostate cancer in addition to PET-PSMA?
How do you reconcile discrepancies in clinical prostate cancer staging with AJCC and NCCN?
Which patients do you consider to be good candidates for salvage local treatment after radiation therapy?
Can you/do you use an androgen receptor blocker alone in patients with metastatic hormone-sensitive prostate cancer who cannot tolerate GnRH-directed therapy?
Do you ever initiate on degarelix and then switch to leuprolide for patients with prostate cancer and cardiac risk factors receiving ADT?
Does a negative staging PSMA PET in a patient with biopsy-proven recurrent prostatic adenocarcinoma change your management?
Is there a role for radiotherapy to the primary in high volume metastatic prostate cancer with well controlled disease on ADT?
Would you treat the prostate in a patient with widely metastatic disease who has CR to all metastatic sites after systemic therapy or ADT?
Do you start prostate radiotherapy sooner in patients receiving neoadjuvant GnRH antagonists relugolix versus agonists such as leuprolide?